Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations.
Insulin action on adipocytes induces two major metabolic effects: stimulation of glucose transport and inhibition of lipolysis. Previously, we have shown that incubated isolated adipocytes from starved (S), and streptozotocin-treated diabetic (D) rats show insulin resistance on glucose transport. It is not known whether insulin resistance is also present on antilipolysis. In this study the antilipolytic action of insulin was investigated. Since basal lipolysis was low, lipolysis was first stimulated by isoproterenol (ISO). This showed that differences existed in sensitivity for ISO among control (C), S, and D adipocytes. We investigated whether changes in adenosine accumulation could attribute to the differences in ISO action and thereby influence insulin action. When endogenous accumulating adenosine was removed by adenosine deaminase and replaced by a fixed concentration (200 nM) of the nonhydrolyzable adenosine analog phenylisopropyladenosine, the differences in ISO action disappeared. This indicates that the sensitivity of C, S, and D adipocytes for ISO is strongly influenced by endogenous adenosine release. The dose-response relationship between insulin and inhibition of ISO-stimulated lipolysis showed that insulin sensitivity was increased and responsiveness unaltered in S and D compared to C adipocytes for incubations with both uncontrolled and controlled adenosine concentrations. This indicates that during S and D states, endogenous adenosine release has no major effect on insulin action. The increased sensitivity for insulin of S and D adipocytes was paralleled by an increased binding of [125I]iodoinsulin. The unaltered responsiveness for insulin indicates that there is no insulin resistance at the postbinding level for antilipolysis, i.e. intracellular processes for antilipolysis are intact. This is in contrast to glucose transport, where insulin resistance exists at the postbinding level during S and D. Thus, insulin resistance is no general phenomenon, but is confined to specific effector systems.
Koopmans
S J
SJ
Department of Endocrinology and Metabolic Diseases, University Hospital, Leiden, The Netherlands.
Sips
H C
HC
Bosman
J
J
Radder
J K
JK
Krans
H M
HM
D000241:Adenosine / Q000378:metabolism*; D000243:Adenosine Deaminase / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology* / Q000031:analogs & derivatives; D007333:Insulin Resistance; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D010660:Phenylisopropyladenosine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013217:Starvation / Q000378:metabolism*
D007328:Insulin; C008147:insulin, iodo-; D010660:Phenylisopropyladenosine; D000243:Adenosine Deaminase; D000241:Adenosine; D007545:Isoproterenol